Make sure to sign up for an account today for exclusive coupons and free shipping on orders over $75!
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 180272-45-1 | Product Number: P2215
(R)-1-Phenyl-1,2,3,4-tetrahydroisoquinoline
×
![]()
×
Purity: >98.0%(GC)(T)
Synonyms:
Product Documents:
| Size | Unit Price | Philadelphia, PA | Portland, OR | Japan* | Quantity |
|---|---|---|---|---|---|
| 200MG |
$158.00
|
3 | 1 | 27 |
|
* Items in stock locally ship in 1-2 business days. Items from Japan stock are able to ship from a US warehouse within 2 weeks. Please contact TCI for lead times on items not in stock. Excludes regulated items and items that ship on ice.
* To send your quote request for bulk quantities, please click on the "Request Quote" button. Please note that we cannot offer bulk quantities for some products.
*TCI frequently reviews storage conditions to optimize them. Please note that the latest information on the storage temperature for the products is described on our website.
| Product Number | P2215 |
| Purity / Analysis Method | >98.0%(GC)(T) |
| Molecular Formula / Molecular Weight | C__1__5H__1__5N = 209.29 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| Store Under Inert Gas | Store under inert gas |
| Condition to Avoid | Air Sensitive |
| CAS RN | 180272-45-1 |
| Reaxys Registry Number | 7794832 |
| PubChem Substance ID | 468592582 |
| MDL Number | MFCD11858641 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(GC) | min. 98.0 % |
| Optical purity(GC) | min. 98.0 ee% |
| Purity(Neutralization titration) | min. 98.0 % |
| Melting point | gt. 80.0 to 84.0 °C |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 83 °C |
GHS
Related Laws:
Transport Information:
| HS Number | 2933.49.6000 |
Application
A Key Synthetic Intermediate of Solifenacin Succinate
This product is a key synthetic intermediate of solifenacin succinate [S0944] which is a selective M3 muscarinic receptor antagonist used for the treatment of overactive bladder (OAB).
References
- Synthesis and Antimuscarinic Properties of Quinuclidin-3-yl 1,2,3,4-Tetrahydroisoquinoline-2-carboxylate Derivatives as Novel Muscarinic Receptor Antagonists
- One-Pot Racemization Process of 1-Phenyl-1,2,3,4-tetrahydroisoquinoline: A Key Intermediate for the Antimuscarinic Agent Solifenacin
- A validated LC method for the chiral purity of (S)-1,2,3,4-tetrahydro-1-phenylisoquinoline: a key intermediate of solifenacin
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.